4//SEC Filing
McFarlane Neil F. 4
Accession 0001062993-22-010000
CIK 0001267565other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:12 PM ET
Size
5.1 KB
Accession
0001062993-22-010000
Insider Transaction Report
Form 4
McFarlane Neil F.
Director
Transactions
- Award
Common Stock
2022-04-06+17,845→ 17,845 total
Footnotes (1)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 6, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001681098
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:12 PM ET
- Size
- 5.1 KB